Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interleukin 2”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00196586
What this trial is testing

Efficacy and Safety of Addition of IL-2 to Pegylated Interferon Alpha 2a and Ribavirin in HIV/HCV Coinfected Patients

Who this might be right for
HIV InfectionsChronic Hepatitis C
French National Agency for Research on AIDS and Viral Hepatitis 75
Early research (Phase 1)Study completedNCT04630769
What this trial is testing

FT516 and IL2 With Enoblituzumab for Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube AdenocarcinomaPrimary Peritoneal Cavity Cancer
Masonic Cancer Center, University of Minnesota 3
Early research (Phase 1)Study completedNCT00329368
What this trial is testing

Safety and Tolerability Study of FolateImmune in Combination With Cytokines in Patients With Refractory or Metastatic Cancer

Who this might be right for
Cancer
Endocyte 13
Not applicableStudy completedNCT00004695
What this trial is testing

Randomized Study of Polyethylene-Glycol-Conjugated Interleukin 2 in Patients With Common Variable Immunodeficiency

Who this might be right for
Common Variable Immunodeficiency
Icahn School of Medicine at Mount Sinai 48
Not applicableStudy completedNCT06216210
What this trial is testing

Assessing the Impact of Opioid-Free Anesthesia Using the Modified Mulimix Technique.

Who this might be right for
Opioid Use
Zulekha Hospitals 60
Testing effectiveness (Phase 2)Study completedNCT00032188
What this trial is testing

Interleukin-2 and Bryostatin 1 in Treating Patients With Advanced Kidney Cancer

Who this might be right for
Recurrent Renal Cell CancerStage III Renal Cell CancerStage IV Renal Cell Cancer
National Cancer Institute (NCI) 65
Testing effectiveness (Phase 2)WithdrawnNCT05218408
What this trial is testing

CYNK-001 IV and IC in Combination With IL2 in Surgical Eligible Recurrent GBM With IDH-1 Wild Type

Who this might be right for
Astrocytoma, Grade IVGlioblastomaGiant Cell Glioblastoma+1 more
Celularity Incorporated
Early research (Phase 1)UnknownNCT06395038
What this trial is testing

IL-2 Plus Abatacept in FTD

Who this might be right for
Frontotemporal Degeneration
The Methodist Hospital Research Institute 10
Early research (Phase 1)UnknownNCT00002616
What this trial is testing

Biological Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer

Who this might be right for
Breast Cancer
University of Illinois at Chicago 36
Early research (Phase 1)Study completedNCT00002321
What this trial is testing

A Phase I Study of the Safety of Proleukin (Aldesleukin) in Combination With Ganciclovir and Antiretroviral Therapy in HIV Seropositive Patients With Cytomegalovirus (CMV) Retinitis

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
Chiron Corporation
Early research (Phase 1)Study completedNCT00774358
What this trial is testing

Interleukin-2 Treatment for Wiskott-Aldrich Syndrome

Who this might be right for
Wiskott-Aldrich Syndrome (WAS)X-linked Thrombocytopenia
Soma Jyonouchi 9
Early research (Phase 1)Study completedNCT00003993
What this trial is testing

Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or Lymphoma

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
National Institute on Aging (NIA) 24
Early research (Phase 1)Study completedNCT00020462
What this trial is testing

Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III, Stage IV, or Recurrent Follicular Lymphoma

Who this might be right for
Lymphoma
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00002681
What this trial is testing

Monoclonal Antibody Plus Interleukin-2 in Treating Patients With Leukemia or Lymphoma

Who this might be right for
LeukemiaLymphoma
Roger Williams Medical Center 25
Testing effectiveness (Phase 2)Study completedNCT04065672
What this trial is testing

Low-dose IL-2 Treatment on Behcet's Disease

Who this might be right for
Behcet's Disease
HeJing 60
Testing effectiveness (Phase 2)Ended earlyNCT05716295
What this trial is testing

A Dose Escalation/Expansion Study of MDK-703 in Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumors
Medikine, Inc. 26
Early research (Phase 1)Ended earlyNCT00054405
What this trial is testing

Interleukin-12 and Interleukin-2 in Treating Patients With Refractory or Recurrent Neuroblastoma

Who this might be right for
Recurrent Neuroblastoma
National Cancer Institute (NCI) 40
Not applicableEnded earlyNCT02922283
What this trial is testing

IL2 Imaging in Metastatic Melanoma

Who this might be right for
Melanoma
University Medical Center Groningen 19
Early research (Phase 1)Study completedNCT02200445
What this trial is testing

Low Dose IL-2 for Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Scott B. Snapper, MD PHD 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT04592653
What this trial is testing

Less Frequent IV Dosing & Tumor Microenvironment (TME) Study of Nemvaleukin Alfa (ALKS 4230) Monotherapy and in Combination With Pembrolizumab (ARTISTRY-3)

Who this might be right for
Advanced Solid Tumor
Mural Oncology, Inc 78
Next Page